Ротация режимов антимикробной терапии в отделении реанимации
Диссертация
Одним из способов снижения уровней антибиотикорезистентности является ротация антимикробных препаратов, которая подразумевает циклическую смену режимов эмпирического лечения определенных инфекций в отделении реанимации. Поскольку развитие антибиотикорезистентности напрямую связано с селективным давлением антимикробных препаратов, после временного ограничения применения некоторых классов… Читать ещё >
Список литературы
- Абдоминальная хирургическая инфекция: клиника, диагностика, антимикробная терапия: Практическое руководство / Под ред. B.C. Савельева, Б. Р. Гельфанда. — М.: Литтерра, 2006. — 168 с. — (Серия «Практические руководства»).
- Белобородов В.Б. Антибактериальная терапия инфекций в отделениях реанимации и интенсивной терапии. Медицинский альманах «Университеты практического врача» Выпуск 2: Антимикробная терапия тяжелых инфекций в стационаре. С. 4−20
- Белобородов В.Б. Деэскалационная антибактериальная терапия — концепция повышения эффективности лечения тяжелых инфекций. РМЖ 2004(5)
- Белобородова Н.В., Лобачева Г. В., Востриков Т. Ю., Попов Д. А. Опыт ротации базовых антибиотиков в отделении реанимации и интенсивной терапии кардиохирургического стационара. Антибиотики и химиотерапия. 2004- 49: 20−25
- Белоусов Ю.Б., Ушкалова Е. А. Нозокомиальные инфекции и принципы их лечения. Фарматека 2001, 12(53).
- Белоцерковский Б.З. Нозокомиальная пнебмония, связанная с искусственной вентиляцией легких, у хирургических больных. Автореф. дисс.. к.м.н. М. 2000 г.
- Белоцерковский Б.З., Гельфанд Е. Б., Попов Т. В., Карабак В. И., Краснов В. Г. Проблемные госпитальные микроорганизмы. Acinetobacter spp. -возбудитель или свидетель? Инфекции в хирургии. 2008 (6) — 1: с. 12−18.
- Березин А.Г., Ромашов О. М., Яковлев C.B., Сидоренко C.B. Характеристики и клиническое значение бета-лактамаз расширенного спектра. Антибиотики и химиотерапия. 2003. 48(7)
- Ю.Европейское руководство по клинической оценке противоинфекционных средств./Под ред. TR. Beam, DN. Gilbert, CM.Kunin. Пер. с англ. под ред. А. Г. Чучалина, Л. С. Страчунского. Смоленск, 1996- 15−40.
- Зубков М.Н. Роль карбапенемов в условиях эскалации антибиотикорезистентности грамотрицательных бактерий. РМЖ 2008(2)
- Карабак В.И. Микробиологический мониторинг за возбудителями нозокомиальных инфекций (на примере отделений реанимации и интенсивной терапии) Антибиотики и химиотерапия, 2000 (3), с. 20−23.
- Попов Т.В. Нозокомиальные инфекции в отделениях интенсивной терапии хирургического профиля. Автореф.. .дисс. к.м.н. М. 2005 г. 27 с.
- Практическое руководство по антиинфекционной химиотерапии. Под ред. JI.C. Страчунского, Ю. Б. Белоусова, С. Н. Козлова. Смоленск: МАКМАХ, 2007.-464 с.
- Проценко Д.Н. Нозокомиальная пневмония у больных в острый период тяжелой травмы. Автореф. дисс.. к.м.н. М., 2003.
- Проценко Д.Н., Гельфанд Б. Р., Игнатенко О. В., Ярошецкий А. И., Яковлев C.B. Цефоперазон/сульбактам (сульперазон) в схемах ротации антибактериальных препаратов в ОРИТ. Consilium medicum 2005 (7) — 4
- Руднов В.А. Формуляр антимикробных средств для отделений реанимации и интенсивной терапии. Клинич Микробиол и Антимикроб Химиотер. 2003- 5(4): 10−18
- Руднов В.А., Ложкин С. Н., Галеев Ф. С., Заболотских И. Б., Кон Е.М. и соавт. Фармакоэпидемиологический анализ лечения пациентов с хирургическим сепсисом в ОРИТ. Результаты многоцентрового исследования. Клинич Микробиол и Антимикро Химиотер 2003, № 2, т. 5
- Сидоренко C.B., Резван С. П. и соавт. Этиология тяжелых госпитальных инфекций в отделениях реанимации и антибиотикорезистентность среди их возбудителей. Антибиотики и химиотерапия. 2005- 50 (2−3): 33−41.
- Страчунский Л.С., Белькова Ю. А., Дехнич А. В. Внебольничные MRS, А -новая проблема антибиотикорезистентности. Клин Микробиол Антимикроб Химиотер. 2005- (7)№ 1: 32−46
- Страну некий JI.C., Козлов С. Н. Современная антимикробная химиотерапия. Руководство для врачей М.: Боргес. 2002. — 436 с.
- Страчунский JI.C., Козлов Р. С., Решедько Г. К. с соавт. Состояние антибиотикорезистентности грамотрицательных возбудителей нозокомиальных инфекций в отделениях интенсивной терапии.// Информационное письмо ЦНИИ эпидемиологии, 1997.
- Яковлев В.П. Настоящее и будущее цефалоспорина IV поколения цефепима. Антибиотики и химиотерапия. 2003. 48(7)
- Яковлев С.В. Критический анализ антибактериальных препаратов для лечения инфекций в стационаре. Инфекции и антимикробная терапия. 2003- 2: 54−56
- Яковлев С.В. Современные подходы к антибактериальной терапии госпитальных инфекций. Лечащий врач. 2005- 9
- Ярошецкий А.И., Проценко Д. Н., Яковлев С. В., Гельфанд Б. Р. Стратегия антибактериальной терапии у пациентов с тяжелой сочетанной травмой: значимость оценки исходной тяжести состояния. Инфекция в хирургии 2004 (2) — 3: 20
- Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Med 1996- 22:387−394
- Alvarez-Lerma F., Palomar M., Josu J. et al. Infections caused by Acinetobacter spp. in critically ill ICU patients.
- Archibald LK, Manning ML, Bell LM, Banerjee S, Jarvis WR. Patient density, nurse-to-patient ratio and nosocomial infection risk in a pediatric cardiac intensive care unit. Pediatr Infect Dis J. 1997−16:1045−8
- Ascar JF. Consequences of bacterial resistance to antibiotics in medical practice. Clin Infect Dis. 1997−24:S17-S18
- Bennett K.M., Scarborough J.E., Sharpe M. et al. Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit. J Trauma. 2007- 63: 307−311
- Bergogne-Berezin E. Current guidelines for the treatment and prevention of nosocomial infections Drugs 1999- 58: 51−67.
- Bergogne-Berezin E., Towner KJ. Acinetobacter spp. as Nosocomial Pathogens: Microbiological, Clinical and Epidemiological Features. Clin Microbial Rev. 1996- 9(2): 148−165.
- Bodi M., Ardanuy C., Olona M. et al. Therapy of ventilator-associated pneumonia: the Tarragona Strategy. Clin Microbiol Infect 2001- 7: 32−33
- Bonhoffer S., Lipsitch M., Levin BR. Evaluating treatment protocols 1.0 prevent antibiotic resistance. Proc Natl Acad Sci USA. 1997- 94:12 106−12 111.
- Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004- 48:1−14
- Bonten M.J., Austin D J., Lipsitch M. Understanding the spread of antibiotic resistant pathogens in hospitals: mathematical models as tools for control. Clin InfectDis 2001−33:1739−1746.
- Bonten M.J., Bergman S.D.C., Spejer H. et al. Characteristics of polyclonal endemicity of Pseudomonas aeruginosa colonization in intensive care units. Implications for infection control. Am J Respir Crit Care Med 1999- 160: 12 121 219
- Bonten M.J., Weinstein R.A. The role of colonization in the pathogenesis of nosocomial infections. Infect Control Hosp Epidemiol. 1996−17:193−200.
- Brown E.M., Nathwani D. Antibiotic cycling or rotation: a systematic review of the evidence of efficacy. J Antimicrob Chemother 2005- 55: 6−9
- Brown RB, Hosmer D, Chen HC, et al. A comparison of infections in different ICUs within the same hospital. Crit Care Med 1985- 13:472−476
- Brun-Buisson C. Do antibiotic protocols impact on resistance?. In: Controversies in Intensive Care Medicine. Eds. Kuhlen R., Moreno R., Ranieri M., Rhodes A. Medizinisch Wissenschaftliche Verlagsgesellschaft. P.183−192
- Brunkhorst F.M. et al. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Int Care Med 2000- 26(Suppl 2): S148−152
- Burke J.P. Antibiotic resistance — squeezing the balloon? JANA 1998- 280: 1270−1271
- Carlet J., Ben Ali A., Chltine A. Epidemiology and control of antibiotic resistance in the intensive care unit. Curr Opin Infect Dis 2004- 17: 309−316
- Carmeli Y., TroilletN., Karchmer A.W., Samore M.H. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med. 1999- 159:1127−1132
- Cartolano G.L., Cheron M., Benabid D. Et al. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glucopeptides (GISA) in 63 French general hospitals. Clin Microbiol Infect 2004- 10: 448−451
- Chambers H. The changing epidemiology of Staphylococcus aureus? Emerg Inf Dis 2001- 7: 178−182
- Chamot E., Boffi E.L., Amari E., Rolmer P. et al. Effectiveness of combination antimicribial therapy for Pseudomonas aeruginosa bacteriemia. Antimicrob Agents Chemother 2003- 47: 2756−2764
- Chandrasekar PH, Kruse JA, Matthews MF. Nosocomial infection among patients in different types of intensive care units at a city hospital. Crit Care Med 1986- 14:508−510
- Chastre J., Fagon J.Y. State of Art: Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002- 165: 867−903
- Chastre J., Wolff M., Fagon J.Y. et al. Comparison of 15 vs 8 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003- 290: 2588−2598
- Cometta A, Calandra T, Gaya H, et al. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother 1996- 40: 1108−1115
- De Mol P. Antibiotic treatment rotation: effect on bacterial resistance in an intensive care unit abst. K-1205. Abstracts of 41st Interscience Conference on
- Antimicrobial Agents and Chemotherapy. Chicago, USA, December 16−19, 2001, p. 411.
- Dennesen P.J.W., van der Ven A.J., Kessels A.G.H. et al. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Resp Crit Care Med 2001- 163: 1371−1375
- Dignani M.C. et al. Stenotromonas maltophilia infections. Semin Resp Crit Care Med. 2003 — 28: 696−698
- Doebbeling BN, Stanley GL, Sheetz CT, et al. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med. 1992- 327:88−93.
- Domingues E.A., Smith T.L., Sanders C.C., Sanders W.E. Jr. A pilot study of antibiotic cycling in a hematology-oncology unit. Infect Control Hosp Epidemiol 2000- 21: S4-S8
- Donchin Y, Gopher D, Olin M, et al. A look into the nature and causes of human errors in the intensive care unit. Crit Care Med 1995- 23:294−300
- Donowitz LG, Wenzel RP, Hoyt JW. High risk of hospital-acquired infection in the ICU patient. Crit Care Med 1982- 10:355−357
- Dubberke E.R., Fraser V J. Чередование и другие стратегии замедления и реверсирования антибиотикорезистентности. St Louis Infect Med 2004- 21(11): 544−556
- Dunagan WC, Woodward RS, Medoff G, et al. Antibiotic misuse in two clinical situations: positive blood culture and administration of aminoglycosides. Rev Infect Dis. 1991−13:405−412.
- Evans R.S., Pestotnic S.L., Classen D.C. et al. A computer-assistedmanagement program for antibiotics and other antiinfective agents. N Engl J Med. 1998- 338: 232−238 j
- Fridkin SK. Routine cycling of antimicrobial agents as an infectioncontrol measure. Clin Infect Dis 2003 -3 6:143 8−1444.
- Fridkin S.K., Gaynes R.P. Antimicrobial resistance in intensive care units. Clin Chest Med 1999- 20: 303−316
- Fridkin SK, Pear SM, Williamson TH, Galgiani JN, Jarvis WR. The role of understaffing in central venous catheter-associated bloodstream infections. Infect Control Hosp Epidemiol. 1996−17:150−8
- Fridkin SK, Welbel SF, Weinstein RA. Magnitude and prevention of nosocomial infections in the intensive care unit. Infect Dis Clin North Am 1997- 11:479−96.
- Garnacho-Montero J. et al. Treatment of multidrug-resistant A. baumannii ventilator-associated pneumonia with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 2003- 36: 1111−1118
- Garnacho-Montero J., Garcia-Garmendia J.L., Barrero-Almondovar A. et al. Impact of adequate empirical therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003- 31: 2742−2751
- Gerding D.N. Antimicrobial cycling: lessons learned from the aminoglycoside experience. Infect Control Hosp Epidemiol 2000- 21(1 Suppl): S12-S17
- Gerding D.N., Larson T.A., Hughes R.A., Weiler M., Shanholtzer C., Peterson L.R. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother 1991- 35: 1284−1290
- Gerding DN, Martone WJ. SHEA conference on antimicrobial resistance: Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol 2000- 21:347−351
- Giantsou E., Liratzopoulos N., Efraimidou E., Panopoulou M., Alepopoulou E. Et al. De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate. Intensive Care Med. 2007- 33: 1533−1540
- Giraud T, Dhainaut JF, Vaxelaire JF, et al. Iatrogenic complications in adult intensive care units: a prospective two-center study. Crit Care Med 1993- 21:40−51
- Goldman D., Larson E. Hand-washing and nosocomial infections. N Engl Med 1992- 327: 120−122 :
- Goldmann DA, Leclair J, Macone A. Bacterial colonization of neonates admitted to an intensive care environment. J Pediatr 1978- 93:288−293
- Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA. 1996−275:234−40
- Gross R., Morgan A.S., Kinky D.E., Weiner M,. Gibson G.A., Fishman N.O. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis 2001−33 :289−295.
- Gruson D, Hilbert G, Vargas F. Et al. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of gram-negative bacilli responsible for ventilator-associated pneumonia. Crit Care Med 2003- 31(7): 1908−1914
- Gruson D., Hilbert G., Vargas F., Valentino R., Bebear C., Allery A., Bebear C., Gbikpi-Benissan G., Cardinaud J.P. Rotation and restricted use ofantibiotics in a medical intensive care unit. Am JRespir Crit Care Med 2000−162:837−843.
- Haley RW, Bregman DA. The role of understaffing and overcrowding in recurrent outbreaks of staphylococcal infection in a neonatal special-care unit. J Infect Dis 1982- 145:875−885
- Haley RW, Cushion NB, Tenover FC, et al. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit. J Infect Dis 1995- 171:614−624
- Hanberger H, Garcia-Rodriguez JA, Gobernado M, et al. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries: French and Portuguese ICU Study Groups. JAMA 1999- 281:67−71
- Harbarth S., et al. Diagnostic value of procalcitonin, interleukin-6 and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001- 164: 396−402
- Harbarth S., Cosgrove S., Carmeli Y. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother 2002- 46: 1619−1628
- Harbarth S., Garbino J.K., Pugin J. et al. Inappropriate initial antimicrobial therapy and its effects on survival in a clinical trial of immunomodulating therapy for severe sepsis Am J Med 2003- 115: 529−535
- Harbarth S., Samore M.H., Lichtenberg D. et al. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections. and antimicrobial resistance. Circulation 2000- 101:2916−2921
- Harbarth S, Sudre P, Dharan S, et al. Outbreak of Enterobacter cloacae related to understaffing, overcrowding, and poor hygiene practices. Infect Control Hosp Epidemiol 1999- 20:598−603
- Higuera F, Rosenthal VD, Duarte P, Ruiz J, Franco G, Safdar N. The effect of process control on the incidence of central venous catheter-associated bloodstream infections and mortality in intensive care units in Mexico. Crit Care Med. 2005−33:2022−7.
- Hiramatsu K, Hanaki H, Ino T, et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997- 40:135−136
- Hooper D.C. Bacterial topoisomerases, anti-topoisomerases, and anti-topoisomerases resistance. Clin Infect Dis. 1998- 27(Suppll): S54-S63
- Howden B.P. et al. Treatment outcomes for serious infections caused by MRS A with reduced vancomycin susceptibility. Clin Infect Dis. 2004- 38: 521 528
- Huebner J, Pier GB, Maslow JN, et al. Endemic nosocomial transmission of Staphylococcus epidermidis bacteremia isolates in a neonatal intensive care unit over 10 years. J Infect Dis 1994- 169:526−531
- Hughes M.G., Evans H.L., Chong T.W. et al. Effect of intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care. unit ward. Crit Care Med. 2004- 32: 53−60
- Hugonnet S, Harbarth S, Sax H, Duncan RA, Pittet D. Nursing resources: a major determinant of nosocomial infection? Curr Opin Infect Dis. 2004- 17: 329−33.
- Hyatt J.M., Schentag J.J. Pharmacodynamic modelling of risk factors for ciprofloxacin resistance in Pseudomonas aeruginosa. Infect Control Hosp Epidemiol. 2000- 21 (Suppl):S9-Sll.
- Ibrahim EH, Ward S, Sherman G, Schaiff R, Fraser VJ, KollefMH. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001−29:1109−1115.
- Jarvis WR. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol. 1996−17:552−7.
- Johanson W.Y., Pierce A.K., Sanford J.P. Changing pharyngeal bacterial flora of hospitalized patients: emergence of Gram-negative bacilli. N Engl J Med 1969- 281: 1137−1140
- Johanson W.Y., Pierce A.K., Sanford J.P. et al. Nosocomial respiratory infections with Gram-negative bacilli: the significance of colonization of the respiratory tract. Ann Int Med 1972- 77: 701−706
- John J.F. Jr. Antibiotic cycling: is it ready for prime time? Infect Control Hosp Epidemiol 2000- 21: 9−11
- John JF Jr, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin InfectDis 1997- 24: 471−485.
- John J.F., Rice L.B. The microbial genetics of antibiotic cycling. Infect Control Hosp Epidemiol. 2000- 21(lSuppl): S22-S31
- Klastersky J., Zinner S.H. Synergistic Combinations of Antibiotics in Gram-negative Bacillary Infections. Rev of Infect Dis, 1982- 4(2): 294.
- Kollef M.H. Is antibiotic Cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit? Clin Inf Dis 2006- 43: S82-S88
- Kollef M.H. Optimizing antibiotic therapy in the intensive care unit setting Crit Care 2001- 5: 189−195
- Kollef M.H., Fraser V.J. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001- 134: 298−314
- Kollef M.H., Micek S.T. Strategies to prevent antimicrobial resistance in the intensive care unit. Crit Care Mad 2005- 33: 1845−1853
- Kollef M.H., Sherman G., Ward S., et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999- 115:462−474
- KollefMH, Vlasnik J, Sharpless L, et al. Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997- 156:1040−1048
- Kollef M.H., Ward S., Sherman G. et al. Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices. Crit Care Med. 2000- 28: 3456−3464
- Kristensen B, Smedegaard HH, Pedersen HM, et al. Antibiotic resistance patterns among blood culture isolates in a Danish county 1981−1995. J Med Microbiol. 1999−48:67−71.
- Landman D., Chockalingam M., Quale J.M. Reduction in the incidence of methicillinresistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Inf Dis. 1999- 28: 1062−1066
- Lepper PM, Grusa E, Reichl H et al. Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2002- 46 (9): 2920−5.
- Lieberman JM. Appropriate antibiotic use and why it is important: the challenges of bacterial resistance. Pediatr Infect Dis J. 2003- 22: 1143−1151.
- Linden P.K., Kusne S., Coley K., Fontes P., Kramer D.J., Paterson D. Use of parenteral colistin fort he treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis 2003- 37: el74−160
- Livermore D.M. Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis 2003- 36: SI 1−23
- Livermore D.M., Yuan M. Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. From intensive care units in Europe. J Antimicrob Chemother 1996- 38: 409−424
- Lode H. Pharmacokinetics and clinical results of parenterally administered new quinolones in humans.- In: Ciprofloxacin, selected of papers at the Intern. Symp. On new Quinolones, Geneva, 1988 (Rev Inf Dis., 1989- 121: suppl. 5): 41−49
- Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997- 111:676 685
- Manthous CA. Toward a more thoughtful approach to fever in critically ill patients. Chest 2000- 117:627−628
- Marik PE. Fever in the ICU. Chest 2000- 117:855−869
- Martinez J. A., Nicolas J.M., Marco F. Et al. Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units. Crit Care Med. 2006- 34: 329−36.
- McGowan JE Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis. 1983- 5: 1033−1048
- McGowan JE Jr. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol 1994- 15:478—483
- McGowan JE Jr. Strategies for study of the role of cycling on antimicrobial use and resistance. Infect Control Hosp Epidemiol. 2000- 21(1 suppl): S36-S43
- McGowan J., Carlet I. Antimicribial resistance. A worldwide problem for health care institutions. Am J Infect Control 1998- 26: 541−543
- McGowan JE Jr, Gerding DN. Does antibiotic restriction prevent resistance? NewHoriz 1996- 4:370−376
- Mebis I., Goossens H., Bmyneel P. et al. Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients. Leukemia. 1998- 12:1627−1629.
- Mehta R.M., Niederman M.S. Резистентность к антибиотикам флоры, вызывающей инфекции у больных отделений реанимации и интенсивной терапии (ОРИТ) Медицинский альманах. Университеты практического врача. Вып. 2 с. 21
- Meisner М. Procalcitonin. A new innovative infection parameter. Biochemical and clinical aspects. 2000 Georg Thieme Verlag. Stuttgart-New York
- Merz L.P., Warren D.K., Kollef M.H., Fraser V.J. Effects of an Antibiotic cycling Program on antibiotic prescribing practices in an intensive care unit. Antimicrob Agents and Chemother 2004- 48(8): 2861−2865
- Merz L.P., Warren D.K., Kollef M.H., Fridkin S.K., Fraser V.J. The impact of an antibiotic cycling program on empirical therapy for gram-negative infections Chest 2006- 130: 1672−1678
- Mesaros N., Nordman P., Plesiat P. Et al. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium. Clin Microbiol Imfect 2007- 13: 560−578
- Micek S.T., Isakow W., Shannon W. et al. Predictors of hospital mortality for patients with severe sepsis treated with Drotrecagin alfs (activated). Pharmacotherapy 2005- 25: 26−34
- Micek S.T., Lloyd A.E., Ritchie D.J. et al. Pseudomonas aeruginosa blood-srteam infections: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother 2005- 49: 1306−1311
- Micek S.T., Ward S., Fraser V.J. et al A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004- 125: 1791−1799
- Molstad S, Cars O. Major change in the use of antibiotics following a national programme: Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA). Scand J Infect Dis. 1999−31:191−195.
- Montravers P., Veber B., Auboyer G. Rt al. Diagnostic and therapeutic management of nosocomial pneumonia in surgical patients: results of the Eole study. Crit Care Med. 2002 (30): 368−375
- Moss W.J., Beers M.C., Johanson E. et al. Pilot study of antibiotic cycling in a pediatric intensive care unit. Crit Care Med 2002- 30: 1877−1822
- Murray B.E. Vancomycic-resistant enterococcal infections. N Engl J Med. 2000- 342: 710−721
- Murthy R. Implementation of strategies of control antimicrobial resistance Chest 2001- 119: 405S-411S
- National Committee for Clinicali Laboratory Standarts. Perfomance standarts for antimicrobial susceptibility testing. 2002.
- National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control. 2003- 31: 481−498.
- National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004- 32: 470−85.
- Neuhauser M.M., Weinstein R.A., Rydman R. et al. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 2003- 289: 885−888
- Niederman M.S. Is «Crop Rotation» of antibiotics the solution to a «resistant» problem in the ICU. Am J Respir Crit Care Med. 1997- 156:10 291 031.
- Nobre V., Harbarth S., Graf J.D., Rohner P., Pugin J. Use of Procalcitonin to Shorten Antibiotic Treatment Duration in Septic Patients. A Randomized Trial. Am J Respir Crit Care Med. 2008 t
- O’Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol. 2002- 23: 759−769.
- Palomar M., Alvarez-Lerma F., De la Cal M.A. et al. ICU-acquired infections in Spain: predominant pathogens abstract. Intensive Care Med 1996- 22(suppl 3):S325
- Paterson D.L., Mulazinoglu L.,.Casellas J.M. et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis. 2000- 30: 773−478
- Paterson D.L., Rice L.B. Empirical antibiotic choice for the seriously ill patients: are minimization of selection of resistant organisms and maximization of individual outcome mutually exclusive? Clin Infect Dis 2003- 36: 1006−1012
- Paul M., Soares-Weiser K., Leibovici L. Beta-lactam monotherapy versus beta-lactam aminoglycoside combination therapy for fever with neutropenia:. sustematic review and metaanalysis. BMJ 2003- 326: 1111
- Perilli M., Ettore D., Segatore B. et al. Overexpression sustem and biochemical profile of CTX-M-3 extended-spectrum beta-lactamase expressed in E. coli. FEMS Microbiol Lett 2004- 241: 229−32
- Pestotnik S.L., Classen D.C. Evans R.S. et al. Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes Ann Intern Med 1996 — 124: 884−890
- Petrak RM, Sexton DJ, Butera ML, et al. The value of an infectious diseases specialist. Clin Infect Dis. 2003−36:1013−1017.
- Pittet D, Hugonnet S, Harbarth S, Mourouga P, Sauvan V, Touveneau S, Perneger TV. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 2000- 356: 1307−1312.
- Ploy MC, Grelaud C, Martin C, et al. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital letter. Lancet 1998- 351:1212
- Prashanth K., Badrinath S. Nosocomial infections due to Acinetobacter species: Clinical findings, risk and prognostic factors. Indian J Med Microbiol. 2006- 24: 39−44.
- Procop G.W., Tuohy M.J., Wilson D.A. et al. Cross-class resistance to non-beta-lactam antimicrobials in extended-spectrum beta-lactamase producing Klebsiella pneumoniae. Am J Clin Pathol 2003- 120: 265−7
- Puzniak LA, Leet T, May field J, Kollef M, Mundy LM. To gown or notto gown: the effect on acquisition of vancomycin-resistant enterococci. Clin Infect Dis 2002−3 5:18−25.
- Quale J, Landman D, Saurina G, et al. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996- 23:1020−1025
- Rahal J. J., Urban C., Horn D. Et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA. 1998- 280: 1233−1237
- Raymond D.P., Pelletier S.J., Crabtree T.D. et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med 2001- 29: 1101−1108
- Rello J. Acinetobacter baumannii infections in the ICU. Customization is the key. Chest 115 (5) May 1999: 1227−1229.
- Rello J., Vidaur L., Sandiumenge A., Rodrigues A. et al. De-escalation therapy in ventilator-associated pneumonia. Crit Care Med. 2004- 32: 21 832 190
- Rice L.B., Ecstein E.C., Devente J. Et al. Ceftazidime resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Center. Clin Infect Dis. 1996- 23: 118−124
- Richards MJ, Edwards JR, Culver DH, et al. Nosocomial infections in medical intensive care units in the United States: National Nosocomial Infections Surveillance System. Crit Care Med 1999- 27:887−892.
- Robert J, Fridkin SK, Blumberg HM, et al. The influence of the composition of the nursing staff on primary bloodstream infection rates in a surgical intensive care unit. Infect Control Hosp Epidemiol 2000- 21:12—17
- Rosenthal VD, Guzman S, Crnich C. Impact of an infection control program on rates of ventilator-associated pneumonia in intensive care units in 2 Argentinean hospitals. Am J Infect Control. 2006−34:58−63.
- Rosenthal VD, Guzman S, Safdar N. Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina. Am J Infect Control. 2005−33:392−7.
- Rosental V.D., Maki D.Y., Salomao R. et al. Device-associated Nosocomial Infections in 55 intensive care units of 8 developing countries. Ann Intern Med 2006- 145: 582−591
- Scannapieco F.A., Stewart E.M., Mylotte J.M. Colonisation of dental plaque by respiratory pathogens in medical intensive care patients Crit Care Med 1992- 20(6): 740−745
- Schacht P., Bruch H., Shysky V. Et al. Overall clinical results of ciprofloxacin. Proc. 14th Intern. Congr. Chemother. Cyoto, 1985- 81−84
- Smith TL, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistance in Staphylococcus aureus: Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 1999- 340:493−501
- Solomkin JS, Dellinger EP, Christou NV, et al. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intraabdominal infections. Ann Surg 1990- 212:581−591
- Tarnow-Mordi WO, Hau C, Warden A, et al. Hospital mortality in relation to staff workload: a 4-year study in an adult intensive-care unit. Lancet 2000- 356:185−189
- Toltzis P., Dul M.J., Hoyen C. et al. The effect of antibiotic rotation on colonisation with antibiotic-resistant bacilli in a neonatal intensive care unit. Pediatrics 2002- 110(4): 707−711
- Torres A, Aznar R, Gatell JM, et al. Incidence, risk and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990- 142:523−528
- Vicca AF. Nursing staff workload as a determinant of methicillin-resistant Staphylococcus aureus spread in an adult intensive therapy unit. J Hosp Infect 1999- 43:109−113
- Vincent J.L. Nosocomial infections in adult intensive care units. Lancet 2003−361:2068−2077
- Warren DK, Fraser VJ. Infection control’measures to limit antimicrobial resistance. Crit Care Med. 2001−29(4 suppl):N128-N134.
- Warren D.K., Hill H.A., Merz L.R. et al. Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant gram-negative bacteria among intensive care unit patients Crit Care Med 2004- 32: 2450−2456
- Washio M, Mizoue T, Kajioka T, et al. Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a Japanese geriatric hospital. Public Health 1997- 111:187−190
- Weber David J., Raasch Ralph, Rutala William A. Nosocomial Infections in the ICU The Growing Importance of Antibiotic-Resistant Pathogens Chest Volume 115 Number 3 March 1999
- Williams JD. b-lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone. Clin Infect Dis 1997- 24: 494−7
- Wilson SE. Carbapenems: monotherapy in intra-abdominal sepsis. Scand J Infect Dis Suppl 1995- 96:28−33
- Winokur P.L., Eidelstain M.V., Stetsiouk O. et al. Russian Klebsiella pneumoniae isolates that express extended-spectrum beta-lactamases. Clin Microbiol Infect 2008- 6: 103−8
- Wood G.C. et al. Tetracyclines for treating multidrugresistant Acinetobacter baumannii VAP. Int Care Med. 2003- 29: 274−278
- Wullt M. et al. A double-blind randomized controlled trial of fusidic acid and metronidazole for treatment of on initial episode of Clostridium difficile associated diarrhea. J Antimicrob Chemother. 2004- 54: 211−216
- Young E.J., Sewell C.M., Koza M.A., Clarridge M.E. Antibiotic resistance patterns during aminoglycoside restriction. Am J Med Sei 1985- 290: 223−227.
- Yu W.L., Pfaller M.A., Winokur P.L., Jones R.N. Cefepime MIC as a predictor of the extended-spectrum bata-lactamase type in Klebsiella pneumoniae. Taiwan Eneerg Infect Dis. 2002- 8: 522−4
- Zack J.E., Garrison T., Trovillion E. et al. Effect of an education program aimed at reducing the occurence of ventilator-associated pneumonia. Crit Care Med. 2002- 30: 2407−2412